Chenguang Biotech Group

SHE:300138 China Farm Products
Market Cap
$911.91 Million
CN¥6.69 Billion CNY
Market Cap Rank
#9182 Global
#1849 in China
Share Price
CN¥13.85
Change (1 day)
-4.02%
52-Week Range
CN¥9.33 - CN¥15.71
All Time High
CN¥19.02
About

ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more

Chenguang Biotech Group (300138) - Total Liabilities

Latest total liabilities as of September 2025: CN¥4.57 Billion CNY

Based on the latest financial reports, Chenguang Biotech Group (300138) has total liabilities worth CN¥4.57 Billion CNY as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Chenguang Biotech Group - Total Liabilities Trend (2007–2024)

This chart illustrates how Chenguang Biotech Group's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Chenguang Biotech Group Competitors by Total Liabilities

The table below lists competitors of Chenguang Biotech Group ranked by their total liabilities.

Company Country Total Liabilities
Guizhou Broadcasting&TV Info
SHG:600996
China CN¥12.24 Billion
Schrödinger, Inc.
F:43Z
Germany €332.31 Million
Suzhou TZTEK Technology Co Ltd
SHG:688003
China CN¥1.98 Billion
XiAn Tian He Defense Technology Co Ltd
SHE:300397
China CN¥1.18 Billion
Zhongnongfa Seed Industry Group Co Ltd
SHG:600313
China CN¥1.75 Billion
Antar Chile
SN:ANTARCHILE
Chile CL$17.00 Billion
Xencor Inc
NASDAQ:XNCR
USA $243.50 Million

Liability Composition Analysis (2007–2024)

This chart breaks down Chenguang Biotech Group's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.39 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.37 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.57 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chenguang Biotech Group's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chenguang Biotech Group (2007–2024)

The table below shows the annual total liabilities of Chenguang Biotech Group from 2007 to 2024.

Year Total Liabilities Change
2024-12-31 CN¥5.87 Billion +17.18%
2023-12-31 CN¥5.01 Billion +34.98%
2022-12-31 CN¥3.71 Billion +16.96%
2021-12-31 CN¥3.17 Billion +22.23%
2020-12-31 CN¥2.59 Billion -6.18%
2019-12-31 CN¥2.77 Billion +71.07%
2018-12-31 CN¥1.62 Billion +29.47%
2017-12-31 CN¥1.25 Billion +29.09%
2016-12-31 CN¥967.46 Million +71.50%
2015-12-31 CN¥564.12 Million +12.89%
2014-12-31 CN¥499.69 Million -22.08%
2013-12-31 CN¥641.26 Million +43.23%
2012-12-31 CN¥447.73 Million +204.24%
2011-12-31 CN¥147.16 Million -31.84%
2010-12-31 CN¥215.92 Million +12.36%
2009-12-31 CN¥192.17 Million -19.02%
2008-12-31 CN¥237.31 Million +177.57%
2007-12-31 CN¥85.49 Million --